Pituitary Tumors: A Comprehensive and Interdisciplinary Approach - Tapa dura

Acerca de los autores

Jürgen Honegger is Professor of Neurosurgery and Vice-Chairman of the Department of Neurosurgery at the Eberhard-Karls University in Tübingen, Germany.
He worked as a resident in the ophthalmological department in Tübingen (1986) and as a resident (1986-1989), senior resident (1991-1994), and consulting neurosurgeon (1994-1997) in neurosurgery at the University of Erlangen-Nürnberg, where he was trained in pituitary surgery by Professor Rudolf Fahlbusch. He spent 1990 at St. Bartholomew’s hospital in London, UK, as a Clinical and Research Fellow to Professors Michael Besser, John Wass, and Ashley Grossman. From 1998 to 2004, he was consultant at the Department of Neurosurgery, University of Fribourg. Since 2005, he has been Vice-Chairman at the Department of Neurosurgery, University of Tübingen, where his main neurosurgical specialities are pituitary surgery, vascular surgery, and epilepsy surgery. Jürgen Honegger was licensed as neurosurgeon in 1987. He was appointed Associate Professor (with a thesis on “Biochemical characterization and surgical treatment of craniopharyngiomas”) in 1997 and Professor in Neurosurgery in 2006. His main clinical and scientific area of activity is in pituitary tumors. In Tübingen, he has built up a Pituitary Surgery Unit that today ranks among the largest units in Germany. Prof. Honegger performs more than 150 operations for pituitary tumors per year. He has organized and hosted pituitary surgery training courses of the German Society of Neurosurgery. He has directed several national studies and surveys on pituitary disorders. Since 2014, he has been the head of the Pituitary Tumor Working Group of the German Society of Endocrinology, which holds the patronage for the German Acromegaly Registry, the German Craniopharyngioma Registry for Adults, and the German Pituitary Tumor Registry.

Martin Reincke is Professor of Endocrinology and Chair of Medical Department IV of the Ludwig-Maximilians University in Munich, a leading institution in German academic medicine.
His research specialties include endocrine hypertension, mineralocorticoid and glucocorticoid action, and stress research. Professor Reincke is a clinician-scientist at heart. He heads a research team that specifically explores the prevalence and relevance of glucocorticoid and mineralocorticoid excess on the epidemiological, clinical, genetic, and molecular levels. He is co-founder of the European Network for the Study of Adrenal Tumors (ENSAT), established in 2000. In 2009, he founded the German Primary Aldosteronism Registry, and in 2012, the German Cushing Registry. Professor Reincke is a member of many national and international societies, including the Endocrine Society and the European Society of Endocrinology. He has served on the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial boards of several international journals, and has served as Teaching Dean of the Faculty from 2006 to 2012 and as president of the German Endocrine Society (2014–2017). Prof. Reincke won the prestigious European Research Council Advanced Grant Award (2.5 million €) in 2016. He is currently President-Elect of the European Society of Endocrinology. His publications include more than 490 MEDLINE-listed manuscripts, which have been cited >12,500 times, and his h-index is 61 (ISI Web of Science).

Stephan Petersenn, MD, ENDOC Center for Endocrine Tumors, Hamburg, Germany. Prof. Stephan Petersenn studied medicine at the University of Kiel, Germany (1984–1987 and 1988–1990) and the University of Vienna, Austria (1987–1988). He is qualified in Internal Medicine (1999), Diabetology (1999), Endocrinology (2000), and Andrology (2007). Previously, he worked in an internship (1991–1992) in the Department of Medicine, University of Kiel, as a Research Fellow (1992–1994) to Professor S Melmed at Cedars-Sinai Medical Center, Los Angeles, USA, as a Resident and Fellow (1995–2000) in the Department of Medicine, University of Hamburg, and as a Senior Physician (2001–2009) in the Division of Endocrinology, University of Duisburg-Essen. In 2009, he founded the ENDOC Center for Endocrine Tumors in Hamburg, while remaining a member of the faculty of the University of Duisburg-Essen. In 2003, he became Associate Professor, and in 2008 Professor of Medicine, at the University of Duisburg-Essen. His research is focused on the diagnosis and treatment of pituitary and adrenal tumors, as well as neuroendocrine tumors. Furthermore, his clinical and basic studies aim for a better understanding of the physiology and pathophysiology of somatostatin receptors. Throughout his career, Prof Petersenn has published more than 160 articles in peer-reviewed journals of high reputation, and he has presented at many international conferences. He is a member of several societies, including the Endocrine society, the European Society of Endocrinology, and the International Pituitary Society.

De la contraportada

Knowledge on pituitary tumors is rapidly progressing. Basic research is on the verge of uncoding the molecular mechanisms involved in tumor genesis. The standard treatment modalities which include surgery, medical treatment and radiosurgery have been further developed and refined. Translational research offers options for innovative treatment concepts for pituitary tumors that are not controlled by standard treatment. Health service research addresses early diagnosis of pituitary tumors and aftercare in the post-treatment follow-up. Pituitary tumors are an example par excellence of a disease that involves multiple medical disciplines and requires an interdisciplinary approach

provides a comprehensive view on preclinical issues, diagnostic procedures, treatment options and post-treatment care in patients with pituitary tumors. The book provides basic and advanced knowledge and addresses a broad audience with interest in pituitary tumors, including physicians, endocrinologists, neuro-surgeons, neuro-radiologists, neuro-ophthalmologists, neuro-pathologists, oncologists, radiotherapists and researchers concerning pituitary tumors. The book not only presents the state-of-the-art for the readers’ own field of specialty, but also provides easy access to the current knowledge of the relevant neighboring disciplines that participate in the interdisciplinary concept. It solves the problem of limited access to comprehensive, multidisciplinary information about pituitary tumors.